Page last updated: 2024-11-03

rabeprazole and Hemothorax

rabeprazole has been researched along with Hemothorax in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Hemothorax: Hemorrhage within the pleural cavity.

Research Excerpts

ExcerptRelevanceReference
"Delayed cardiac tamponade and hemothorax occurred as complications in 6 and 1 patients, respectively, in Group II from 5 days to 3 months postoperatively."1.35Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin. ( Furukawa, N; Hata, M; Hayasaka, M; Kimura, H; Minami, K; Niino, T; Osaka, S; Sezai, A; Taoka, M; Unosawa, S; Yoda, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hata, M1
Hayasaka, M1
Sezai, A1
Niino, T1
Yoda, M1
Unosawa, S1
Taoka, M1
Osaka, S1
Furukawa, N1
Kimura, H1
Minami, K1

Other Studies

1 other study available for rabeprazole and Hemothorax

ArticleYear
Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin.
    The Thoracic and cardiovascular surgeon, 2008, Volume: 56, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anticoagulants; Cardiac Surgical Procedures; Cardiac

2008